Table 1

Baseline characteristics of people with or without dementia by exposure group, N (%)

CharacteristicPeople with dementia (N=447)People without dementia (N=234 867)
NRT (N=409)Varenicline (N=38)TotalNRT (N=159 327)Varenicline (N=75 540)Total
Age at time of first prescription*71.1 (12.2)66.2 (15.1)70.7 (12.6)46.2 (15.5)44.4 (13.2)45.6 (14.8)
Sex (male)186 (45.5%)19 (50.0%)205 (45.9%)73 674 (46.2%)37 676 (49.9%)111 350 (47.4%)
Index of multiple deprivation score (IMD)†‡343333
No of GP visits 1 year prior to first prescription*11.5 (9.0)15.3 (9.9)11.8 (9.1)8.9 (7.4)7.3 (6.1)8.4 (7.0)
BMI*†24.6 (5.1)25.7 (6.3)24.7 (5.4)26.5 (5.7)26.5 (5.4)26.5 (5.6)
Year of first prescription†201020102010200920102009
Days of history*3573.8 (2181.2)3450.3 (2327.4)3563.3 (2191.5)3052.9 (1907.1)3164.8 (1986.2)3088.9 (1933.6)
Comorbidity ever (Charlson Index)354 (86.6%)28 (73.7%)382 (85.5%)59 489 (37.3%)24 017 (31.8%)83 506 (35.6%)
Alcohol misuse ever104 (25.4%)11 (29.0%)115 (25.7%)13 890 (8.7%)4759 (6.3%)18 649 (7.9%)
Self-harm ever67 (16.4%)9 (23.7%)76 (17.0%)17 232 (10.8)6652 (8.8%)23 884 (10.2%)
Ever anxiety and stress related disorders151 (36.9%)16 (42.1%)167 (37.4%)44 381 (27.9%)17 377 (23.0%)61 758 (26.3%)
Other behavioural/neurological disorder ever30 (7.3%)6 (15.8%)36 (8.1%)8693 (5.5%)2956 (3.9%)11 649 (5.0%)
Ever depression217 (53.1%)26 (68.4%)243 (54.4%)65 343 (41.0%)26 097 (34.6%)91 440 (38.9%)
Ever antidepressants273 (66.7%)28 (73.7%)301 (67.3%)79.584 (50.0%)32 230 (42.7%)111 814 (47.6%)
Ever antipsychotics175 (42.8%)13 (34.2%)188 (42.1%)28 972 (18.2%)9792 (13.0%)38 764 (16.5%)
Ever hypnotics/anxiolytics238 (58.2%)20 (52.6%)258 (57.7%)60 092 (37.7%)25 134 (33.3%)85 226 (36.3%)
  • *Data presented are mean and SD.

  • †Data presented are median.

  • ‡Missing data: BMI data were missing for 14.1% (N=33 059); IMD data were missing for 43.6% (N=102 657).

  • BMI, body mass index; GP, general practitioner.